HRTX - Heron Therapeutics GAAP EPS of -$0.07 beats by $0.09 revenue of $34.22M beats by $3M
2024-03-12 16:05:59 ET
More on Heron Therapeutics
- Heron Therapeutics Is Out Of Survival Mode
- Upcoming FDA Decision: Heron Therapeutics' ZYNRELEF SNDA
- Heron Therapeutics Gets Back On Track
- Heron Therapeutics Q4 2023 Earnings Preview
- Heron Therapeutics rises on securing label expansion for pain therapy